{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:51:27Z","timestamp":1791697887542,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.tvjl.2022.105831","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:16:53Z","timestamp":1650921413000},"page":"105831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The effect of pergolide mesylate on adrenocorticotrophic hormone responses to exogenous thyrotropin releasing hormone in horses"],"prefix":"10.1016","volume":"285","author":[{"given":"A.E.","family":"Durham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2022.105831_bib1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1939-1676.2011.00810.x","article-title":"Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction","volume":"25","author":"Beech","year":"2011","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2022.105831_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2460\/javma.231.3.417","article-title":"Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia","volume":"231","author":"Beech","year":"2007","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2022.105831_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2460\/javma.238.10.1305","volume":"238","author":"Beech","year":"2011","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2022.105831_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tvjl.2018.07.008","article-title":"Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia","volume":"238","author":"Byrne","year":"2018","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2022.105831_bib5","first-page":"261","article-title":"Equine pituitary pars intermedia dysfunction: an international survey of veterinarians\u2019 approach to diagnosis, management, and estimated prevalence","volume":"81","author":"Carmalt","year":"2017","journal-title":"Canadian Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2022.105831_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.2042-3306.2011.00444.x","article-title":"Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction","volume":"44","author":"Copas","year":"2012","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2022.105831_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.domaniend.2014.02.004","article-title":"Influence of feeding status, time of the day, and season on baseline adrenocorticotropic hormone and the response to thyrotropin releasing hormone-stimulation test in healthy horses","volume":"48","author":"Diez de Castro","year":"2014","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.tvjl.2022.105831_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/evj.13292","article-title":"Clinically and temporally specific diagnostic thresholds for plasma ACTH in the horse","volume":"53","author":"Durham","year":"2021","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2022.105831_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/eve.12160","article-title":"Pituitary pars intermedia dysfunction: diagnosis and treatment","volume":"26","author":"Durham","year":"2014","journal-title":"Equine Veterinary Education"},{"key":"10.1016\/j.tvjl.2022.105831_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1939-1676.2011.0712.x","article-title":"Seasonal changes in plasma adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses","volume":"25","author":"Funk","year":"2011","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2022.105831_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jevs.2013.11.001","article-title":"Comparison of insulin and glucose metabolism in horses with pituitary pars intermedia dysfunction treated versus not treated with pergolide","volume":"34","author":"Gehlen","year":"2014","journal-title":"Journal of Equine Veterinary Science"},{"key":"10.1016\/j.tvjl.2022.105831_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/vetr.142","article-title":"Pergolide dosing compliance and factors affecting the laboratory control of equine pituitary pars intermedia dysfunction","volume":"189","author":"Hague","year":"2021","journal-title":"The Veterinary Record"},{"key":"10.1016\/j.tvjl.2022.105831_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jvim.16017","article-title":"Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses","volume":"35","author":"Horn","year":"2021","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2022.105831_bib14","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1111\/jvim.16281","article-title":"Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses","volume":"35","author":"Kam","year":"2021","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2022.105831_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1159\/000125075","article-title":"Modulation of plasma glucose levels by thyrotropin-releasing hormone administered intracerebroventricularly in the rat","volume":"48","author":"Marubashi","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tvjl.2022.105831_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvp.12339","article-title":"Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction","volume":"40","author":"McFarlane","year":"2017","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2022.105831_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.domaniend.2005.07.005","article-title":"Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants","volume":"30","author":"McFarlane","year":"2006","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.tvjl.2022.105831_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/evj.13500","article-title":"The accuracy of ACTH as a biomarker for pituitary pars intermedia dysfunction in horses: A systematic review and meta-analysis","volume":"54","author":"Meyer","year":"2021","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2022.105831_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.domaniend.2020.106531","article-title":"Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses","volume":"74","author":"Miller","year":"2021","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.tvjl.2022.105831_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing\u2019s disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2022.105831_bib21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1210\/endo-114-4-1344","article-title":"Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro*","volume":"114","author":"Szabo","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.tvjl.2022.105831_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0006-291X(71)90644-9","article-title":"Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture","volume":"43","author":"Tashjian","year":"1971","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.tvjl.2022.105831_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2020.105562","article-title":"Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: a systematic review","volume":"266","author":"Tatum","year":"2020","journal-title":"Veterinary Journal"},{"key":"10.1016\/j.tvjl.2022.105831_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2021.105695","article-title":"Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: a systematic review","volume":"275","author":"Tatum","year":"2021","journal-title":"Veterinary Journal"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023322000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023322000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:32:58Z","timestamp":1761071578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023322000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"alternative-id":["S1090023322000466"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2022.105831","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of pergolide mesylate on adrenocorticotrophic hormone responses to exogenous thyrotropin releasing hormone in horses","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2022.105831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105831"}}